Gaxos.ai Inc. Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Gaxos.ai Inc. Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Roseland, NJ, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (Nasdaq: GXAI), ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,449,277 shares of its common stock at a purchase price of $3.45 per share in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, the Company will issue unregistered warrants to purchase up to 1,449,277 shares of common stock. The warrants will have an exercise price of $3.32 per share, will be exercisable upon issuance and expire three years following the date of issuance. The closing of the offering is expected to occur on or about December 20, 2024, subject to the satisfaction of customary closing conditions.
新澤西州羅斯蘭德,2024年12月19日(全球新聞社)——Gaxos.ai Inc.(納斯達克代碼:GXAI),(「Gaxos」或「公司」),是一家開發人工智能應用於各個領域的公司,今天宣佈已達成最終協議,購買和出售共計1,449,277股普通股,購買價格爲每股3.45美元,註冊直接發行價格符合納斯達克規則。此外,在同時進行的定向增發中,公司將發行未註冊的Warrants,以購買最多1,449,277股普通股。Warrants的行使價格爲每股3.32美元,發行時可行使,並在發行日期後三年到期。該發行的結束預計在2024年12月20日左右進行,前提是滿足慣例的結束控制項。
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
The aggregate gross proceeds to the Company from the offering are expected to be approximately $5 million, before deducting the placement agent fees and other offering expenses payable by the Company. The Company currently intends to use the net proceeds from the offering for working capital and other general corporate purposes.
The aggregate gross proceeds to the Company from the offering are expected to be approximately $500萬, before deducting the placement agent fees and other offering expenses payable by the Company. The Company currently intends to use the net proceeds from the offering for working capital and other general corporate purposes.
The shares of common stock (but not the warrants issued in the private placement or the shares of common stock underlying such warrants) are being offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-283758) filed with the Securities and Exchange Commission ("SEC") on December 12, 2024 and became effective on December 18, 2024. The registered direct offering of the shares of common stock is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. The prospectus supplement and the accompanying prospectus relating to the shares of common stock being offered in the registered direct offering will be filed with the SEC and be available at the SEC's website at www.sec.gov. Electronic copies of the prospectus supplement and the accompanying prospectus relating to the registered direct offering may also be obtained, when available, by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by telephone at (212) 856-5711 or e-mail at placements@hcwco.com.
The shares of common stock (but not the Warrants issued in the private placement or the shares of common stock underlying such Warrants) are being offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-283758) filed with the Securities and Exchange Commission ("SEC") on December 12, 2024 and became effective on December 18, 2024. The registered direct offering of the shares of common stock is being made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. The prospectus supplement and the accompanying prospectus relating to the shares of common stock being offered in the registered direct offering will be filed with the SEC and be available at the SEC's website at www.sec.gov. Electronic copies of the prospectus supplement and the accompanying prospectus relating to the registered direct offering may also be obtained, when available, by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by telephone at (212) 856-5711 or e-mail at placements@hcwco.com.
The warrants described above are being issued in a concurrent private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act"), and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the warrants and underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws.
上述Warrants是在1933年證券法第4(a)(2)節及其下規定的D條例的同時定向增發中發行的,並且與Warrants相關的普通股尚未根據證券法或適用的州證券法進行註冊。因此,除非根據有效的註冊聲明或適用的證券法註冊要求的豁免條款,這些Warrants和相關的普通股不得在美國進行發行或賣出。
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
本新聞稿不得構成出售或索求購買本文所述任何證券的報價,也不得在任何州或管轄區進行這些證券的銷售,在這些州或管轄區裏,任何這樣的報價、索求或銷售在未註冊或未符合該州或管轄區的證券法之前都是不合法的。
About Gaxos.ai Inc.
關於Gaxos.ai Inc.
Gaxos.ai isn't just developing applications; its aim is to redefine the human-AI relationship. Our offerings are being expanded to include health and wellness, as well as gaming. We're committed to addressing health, longevity, and entertainment, through AI solutions.
Gaxos.ai不僅僅在開發應用程序;它的目標是重新定義人類與人工智能的關係。我們的產品正在擴展,包括健康與保健以及遊戲。我們致力於通過人工智能解決方案來應對健康、長壽和娛樂方面的問題。
Forward-Looking Statements
前瞻性聲明
All statements other than statements of historical fact in this announcement are forward-looking statements that involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs and are subject to market and other conditions. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. Forward-looking statements include statements regarding, the ability of the Company to consummation of the offering, the satisfaction of the closing conditions of the offering and the use of proceeds therefrom. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's filings with the SEC.
本公告中,除歷史事實的陳述外,其他所有聲明均爲前瞻性聲明,涉及已知和未知的風險和不確定性,基於公司認爲可能影響其財務狀況、經營成果、業務策略和財務需求的當前期望和未來事件及金融趨勢的預測,且這些聲明受到市場和其他控制項的影響。投資者可以通過如「可能」、「將」、「期望」、「預期」、「旨在」、「估計」、「打算」、「計劃」、「相信」、「潛在」、「繼續」、「可能」等詞語或短語來識別這些前瞻性聲明。前瞻性聲明包括關於公司完成發行、滿足發行的關機控制項和使用募集資金等方面的聲明。公司沒有義務更新前瞻性聲明,以反映隨後發生的事件或情況,或對其期望的變化,除非法律要求。儘管公司認爲這些前瞻性聲明中表達的期望是合理的,但無法保證這些期望會正確,且公司提醒投資者,實際結果可能與預期結果顯著不同,鼓勵投資者查看可能影響公司未來成果的其他因素,參考公司向證券交易委員會(SEC)提交的報告。
Gaxos.ai Inc. Company Contact
Gaxos.ai Inc. 公司聯繫方式
Investor Relations
投資者關係
E: ir@gaxos.ai
E: ir@gaxos.ai
T: 1-888-319-2499
T: 1-888-319-2499
譯文內容由第三人軟體翻譯。